Insulet (PODD) FCF Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Insulet | 10.37 Bn | 9.89 Bn | 529.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,933.00 |
| Dec 31, 2025 | -211.00 |
| Sep 30, 2025 | 1,093.00 |
| Jun 30, 2025 | 3,840.00 |
| Mar 31, 2025 | 1,511.00 |
| Dec 31, 2024 | 6,662.00 |
| Sep 30, 2024 | 256.00 |
| Jun 30, 2024 | -16.00 |
| Mar 31, 2024 | 1,871.00 |
| Dec 31, 2023 | -176.00 |
| Sep 30, 2023 | -5,317.00 |
| Jun 30, 2023 | 6,862.00 |
| Mar 31, 2023 | 1,482.00 |
| Dec 31, 2022 | 1,617.00 |
| Sep 30, 2022 | 388.00 |
| Jun 30, 2022 | 278.00 |
| Mar 31, 2022 | 3,991.00 |
| Dec 31, 2021 | -317.00 |
| Sep 30, 2021 | -807.00 |
| Jun 30, 2021 | -1,277.00 |
| Mar 31, 2021 | 113.00 |
| Dec 31, 2020 | 4,979.00 |
| Sep 30, 2020 | -115.00 |
| Jun 30, 2020 | -834.00 |
| Mar 31, 2020 | 1,021.00 |
| Dec 31, 2019 | -5,363.00 |
| Sep 30, 2019 | 1,016.00 |
| Jun 30, 2019 | 1,760.00 |
| Mar 31, 2019 | 70.00 |
| Dec 31, 2018 | 2,725.00 |
| Sep 30, 2018 | 5,840.00 |
| Jun 30, 2018 | -6,605.00 |
| Mar 31, 2018 | -1,365.00 |
| Dec 31, 2017 | 1,009.00 |
| Sep 30, 2017 | 2,679.00 |
| Jun 30, 2017 | 3,094.00 |
| Mar 31, 2017 | -2,451.00 |
| Dec 31, 2016 | 3,764.00 |
| Sep 30, 2016 | -197.00 |
| Jun 30, 2016 | 3,753.00 |
| Mar 31, 2016 | 2,125.00 |
| Dec 31, 2015 | 1,190.00 |
| Sep 30, 2015 | 6,572.00 |